BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4717706)

  • 21. Cellular immune reactions in human acute leukemia.
    Herberman RB
    Hamatol Bluttransfus; 1974; 14():107-18. PubMed ID: 4615044
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
    Holmes EC; Roth JA; Morton DL
    Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed cutaneous hypersensitivity reaction in breast cancer patients.
    Jain P; Khanna NN
    J Indian Med Assoc; 1988 Jan; 86(1):5-7. PubMed ID: 3288701
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapidly progressing breast cancer (poussée évolutive) in Tunisia: studies on delayed hypersensitivity.
    Mourali N; Levine PH; Tabanne F; Belhassen S; Bahi J; Bennaceur M; Herberman RB
    Int J Cancer; 1978 Jul; 22(1):1-3. PubMed ID: 681022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
    Shiga T; Kawauchi A; Kamiya K; Ishii J; Uzawa R; Gomi K
    Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
    Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
    Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
    [No Abstract]   [Full Text] [Related]  

  • 27. [Demonstration, by means of allogenic antigens, of an antitumoral immunity with cellular mediation in humans].
    Febvre H; Moutte A; Constans JP
    C R Acad Hebd Seances Acad Sci D; 1972 Nov; 275(19):2191-4. PubMed ID: 4346143
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity and MuMTV-like antigenicity of human breast cancer tissues.
    Black MM
    Contemp Top Immunobiol; 1977; 6():239-62. PubMed ID: 194749
    [No Abstract]   [Full Text] [Related]  

  • 29. Cutaneous delayed hypersensitivity responses of patients with retinoblastoma to standard recall antigens and crude membrane extracts of retino-blastoma tissue culture cells.
    Char DH; Herberman RB
    Am J Ophthalmol; 1974 Jul; 78(1):40-4. PubMed ID: 4600659
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
    Burdick JF; Wells SA; Herberman RB
    Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular immunity to breast carcinoma and malignant melanoma.
    Cochran AJ; Mackie RM; Thomas CE; Grant RM; Cameron-Mowat DE; Spilg WG
    Br J Cancer Suppl; 1973 Aug; 1():77-82. PubMed ID: 4804293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delayed hypersensitivity reaction in malignant melanoma].
    Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
    Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
    [No Abstract]   [Full Text] [Related]  

  • 33. Delayed cutaneous hypersensitivity reactions to concanavalin A-binding tumour membrane components.
    Cunningham TJ; Weber PB; Teitelbaum HD; Blumenstock FA; Charniga C
    Clin Exp Immunol; 1975 Jul; 21(1):97-100. PubMed ID: 1181077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure.
    Black MM; Leis HP; Shore B; Zachrau RE
    Cancer; 1974 Apr; 33(4):952-8. PubMed ID: 4594599
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma.
    McCoy JL; Jerome LF; Dean JH; Cannon GB; Alford TC; Doering T; Herberman RB
    J Natl Cancer Inst; 1974 Jul; 53(1):11-7. PubMed ID: 4835097
    [No Abstract]   [Full Text] [Related]  

  • 36. Responses of neoplasms to local immunotherapy.
    Klein E; Holtermann OA; Case RW; Milgrom H; Rosner D; Adler S
    Am J Clin Pathol; 1974 Aug; 62(2):281-9. PubMed ID: 4602090
    [No Abstract]   [Full Text] [Related]  

  • 37. A guinea pig model for tumor immunology. A summary.
    Rapp HJ
    Isr J Med Sci; 1973 Mar; 9(3):366-74. PubMed ID: 4122812
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro cellular immunity in mammary carcinoma.
    Jones BM; Turnbull AR
    Br J Cancer; 1974 Apr; 29(4):337-9. PubMed ID: 4852381
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic responses in cancer patients.
    Solowey AC; Rapaport FT
    Surg Gynecol Obstet; 1965 Oct; 121(4):756-60. PubMed ID: 5838283
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
    Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
    J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.